APDN Announces Linea™ DNA Follow-On Order for Cancer Diagnostic Application
November 28th, 2023
News
All Categories
ACDL
APDN in the News
CertainT®
Coronavirus
Corporate/Financial News
Investors
Large-Scale DNA Production
Linear DNA
mpox
PGx
Press Release
Uncategorized
Vaccines
APDN Extends Application of Linea™ IVT Platform to saRNA (self-amplifying mRNA)
November 16th, 2023
APDN Ships First saRNA (self-amplifying mRNA) IVT Template Generated by Linea™ DNA Platform
November 9th, 2023
APDN Partners with Cornell University College of Veterinary Medicine to Accelerate Development of Veterinary Vaccine Platform Targeting Diseases that Impact High-Value Animals
September 14th, 2023
APDN Appoints Beverly Wolgast as Executive Director of Quality and cGMP Programs
September 6th, 2023
Applied DNA Announces Availability and First Customer Shipment of New Linea™ IVT Evaluation Kit
August 29th, 2023
APDN Files Provisional Patent Applications for Methods of Double-Stranded RNA Mitigation in Next-Gen mRNA Production
August 23rd, 2023
Applied DNA Reports Third Quarter Fiscal 2023 Financial Results and Provides Corporate Update
August 10th, 2023
APDN to Report FQ3’23 Financial Results; Investor Conference Call/Webcast 8/10
August 7th, 2023